Skip to main content
. 2022 Jun 14;2022:3888734. doi: 10.1155/2022/3888734

Table 1.

The number of CD11b+, CD14+, or complement factor I (CFI)+ cells and the staining score of iC3b in skin biopsies from patients with immunocomplex-mediated cutaneous small vessel vasculitis.

CD11b (cells/mm2) CD14 (cells/mm2) CFI (cells/mm2) iC3b (score)
Nonlesional skin (n = 10) 264 ± 162 224 ± 117 124 ± 144 1.3 ± 0.5
Initial petechiae (n = 10) 853 ± 605 576 ± 330# 270 ± 168& 1.6 ± 0.7
Palpable purpura (n = 8) 2040 ± 1202∗∗ 1115 ± 606## 219 ± 69 (n = 9) 2.6 ± 0.7∗∗∗

The results are expressed as the mean ± standard deviation. “∗” denotes p = 0.014 and “∗∗” p = 0.004 when the CD11b+ cell numbers in the initial petechial lesion and palpable purpura, respectively, were compared to the corresponding cell numbers in the nonlesional skin (paired t-test); “#” denotes p = 0.008 and “##” p = 0.0024 when the CD14+ cell numbers in the initial petechial lesion and palpable purpura, respectively, were compared to the corresponding cell numbers in the nonlesional skin (paired t-test); “&” denotes p = 0.0169 when the CFI+ cell numbers in the initial petechial lesion were compared to the corresponding cell numbers in the nonlesional skin (paired t-test); and “∗∗∗” denotes p = 0.003 when the iC3b scores in the palpable purpura were compared to the corresponding scores in the nonlesional skin (mixed model analysis).